Skip to main content

Advertisement

SpringerLink
Log in

Somatostatin-receptor scintigraphy in Graves' orbitopathy

  • Editorial
  • Published:
European Journal of Nuclear Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Krenning EP, Bakker WH, Breeman WAP, Koper JW Kooij PPM, Ausema L, Lameris JS, Lamberts SWJ. Localisation of endocrine-related tumours with radioiodinated analogues of somatostatin.Lancet 1989; 1: 242–244.

    Google Scholar 

  2. Krenning EP, Kwekkeboom DJ, Bakker WH, Breeman WAP, Kooij PPM, Oei HY, Van Hagen PM, Postema PTE, De Jong M, Reubi JC, Visser TJ, Reijs AER, Hofland LJ, Koper JW, Lamberts SWJ. Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]octreotide and [123I-Tyr3]octreotide: the Rotterdam experience with more than 1000 patients.Eur J Nucl Med 1993; 20: 716–731.

    Google Scholar 

  3. Lamberts SWJ, Bakker WH, Reubi JC, Krenning EP. Somatostatin receptor imaging in the localization of endocrine tumours.N Engl J Med 1990; 323: 1246–1249.

    Google Scholar 

  4. Van Hagen PM, Krenning EP, Reubi JC, Mulder AH, Bakker WH, Oei HY, Lowenberg B, Lamberts SWJ. Somatostatin analogue scintigraphy of malignant lymphomas.Br J Haematol 1994; 83: 75–79.

    Google Scholar 

  5. Van Eijck C, Krenning EP, Bootsma AH, Oei HY, Van Pel R, Lindemans J, Jeekel J, Reubi JC, Lamberts SWJ. Somatostatin-receptor scintigraphy in primary breast cancer.Lancet 1994; 343: 640–643.

    Google Scholar 

  6. Van Hagen PM, Krenning EP, Reubi JC, Kwekkeboom DJ, Bakker WH, Mulder AH, Laissue I, Hoogsteden HC, Lamberts SWJ. Somatostatin analogue scintigraphy in granulomatous diseases.Eur J Nucl Med 1994; 21: 497–502.

    Google Scholar 

  7. Van Hagen PM, Markusse HM, Lamberts SWJ, Kwekkeboom SWJ, Reubi JC, Krenning EP. Somatostatin receptor imaging. The presence of somatostatin receptors in rheumatoid arthritis.Arthritis Rheum 1994; 37: 1521–1527.

    Google Scholar 

  8. Postema PTE, Krenning EP, Wijngaarde R, Kooij PPM, Oei HY, Van den Bosch WA, Reubi JC, Wiersinga WM, Hooijkaas H, Van der Loos T, Poublon RML, Lamberts SWJ, Hennemann G. [111In-DTPA-d-Phe1]octreotide scintigraphy in thyroidal and orbital Graves' disease: a parameter for disease activity?J Clin Endocrinol Metab 1994; 79: 1845–1851.

    Google Scholar 

  9. Kahaly G, Diaz M, Hahn K, Beyer J, Bockisch A. Indium-111-pentetreotide scintigraphy in Graves' ophthalmopathy.J Nucl Med 1995; 36: 550–554.

    Google Scholar 

  10. Moncayo R, Baldissera I, Metzler R, Decristoforo C, Riccabona G. Octreoscan in the evaluation of active Graves' ophthalmopathy [abstract].Thyroid 1995; 5 Suppl 1: 69.

    Google Scholar 

  11. Moncayo R, Dessl A, Judmaier W, Baldissera I, Kendler D, Watfah C, Szantkay A, DeCristoforo C, Hackl M, Fridrich L, Riccabona G. Octreoscan and magnetic resonance imaging of endocrine orbitopathy.Eur J Nucl Med 1994; 21: 754.

    Google Scholar 

  12. Krenning EP, Kwekkeboom DJ, Pauwels S, Kvols LK, Reubi JC. Somatostatin receptor scintigraphy.Nucl Med Ann 1995; 1–50.

  13. Hales IB, Rundle FF. Ocular changes in Graves' disease. A long-term follow-up study.Q J Med 1960; 29: 113–126.

    Google Scholar 

  14. Perros P, Crombie AL, Kendall-Taylor P. Natural history of thyroid associated opthalmopathy.Clin Endocrinol 1995; 42: 42–50.

    Google Scholar 

  15. Bartalena L, Marcocci C, Chiovato L, et al. Orbital cobalt irradiation combined with systemic corticosteroids or alone.J Clin Endocrinol Metab 1983; 56: 1139–1144.

    Google Scholar 

  16. Mourits MP, Koornneef L, Wiersinga WM, Prummel ME, Berghout A, Van der Gaag R. Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach.Br J Ophthalmol 1989; 73: 639–644.

    Google Scholar 

  17. Kahaly G, Schuler M, Sewell AC, Bernard G, Beyer J, Krause U. Urinary glycosaminoglycans in Graves' ophthalmopathy.Clin Endocrinol 1990; 33: 35–44.

    Google Scholar 

  18. Krassas GE, Dumas A, Pontikides N, Kaltsas. Somatostatin receptor scintigraphy and octreotide treatment in patients with thyroid eye disease.Clin Endocrinol 1995; 42: 571–580.

    Google Scholar 

  19. Chang TC, Kao SCS, Huang KM. Octreotide and Graves' ophthalmopathy and pretibial myxedema.Br Med J 1992; 304: 158.

    Google Scholar 

  20. Krenning EP, Postema PTE, Wijngaarde R, Van den Bosch WA, Kooij PPM, Poublon RML, Oei HY. [111In-DTPA-d-Phe1]octreotide scintigraphy in thyroidal and orbital Graves' disease: follow-up during treatment [abstract].Thyroid 1995; 5 Suppl 1: 183.

    Google Scholar 

  21. vanHagen PM. Somatostatin and substance-P analogues. Applications in autoimmune and haematological diseases. Thesis, Erasmus University Rotterdam, The Netherlands, 1995.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine III, University Hospital Rotterdam, The Netherlands

    P. T. E. Postema & E. P. Krenning

  2. Department of Nuclear Medicine, University Hospital Rotterdam, The Netherlands

    P. T. E. Postema, D. J. Kwekkeboom & E. P. Krenning

  3. Department of Immunology, University Hospital Rotterdam, The Netherlands

    P. M. van Hagen

Authors
  1. P. T. E. Postema
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. J. Kwekkeboom
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. M. van Hagen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E. P. Krenning
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Postema, P.T.E., Kwekkeboom, D.J., van Hagen, P.M. et al. Somatostatin-receptor scintigraphy in Graves' orbitopathy. Eur J Nucl Med 23, 615–617 (1996). https://doi.org/10.1007/BF00834521

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00834521

Search

Navigation